Effects of Physical, Chemical, and Biological Stimulus on h-MSC Expansion and Their Functional Characteristics

被引:29
作者
Castilla-Casadiego, David A. [1 ]
Reyes-Ramos, Ana M. [2 ]
Domenech, Maribella [2 ]
Almodovar, Jorge [1 ]
机构
[1] Univ Arkansas, Ralph E Martin Dept Chem Engn, 3202 Bell Engn Ctr, Fayetteville, AR 72701 USA
[2] Univ Puerto Rico Mayaguez, Dept Chem Engn, Call Box 9000, Mayaguez, PR 00681 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Human adult mesenchymal stem or stromal cells; Cell manufacturing; Cell therapy; MESENCHYMAL STEM-CELLS; HOLLOW-FIBER BIOREACTOR; FETAL BOVINE SERUM; STROMAL CELLS; INTERFERON-GAMMA; IN-VITRO; SUBSTRATE STIFFNESS; SINGLE-USE; SELF-RENEWAL; IMMUNOMODULATORY PROPERTIES;
D O I
10.1007/s10439-019-02400-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Human adult mesenchymal stem or stromal cells (h-MSC) therapy has gained considerable attention due to the potential to treat or cure diseases given their immunosuppressive properties and tissue regeneration capabilities. Researchers have explored diverse strategies to promote high h-MSC production without losing functional characteristics or properties. Physical stimulus including stiffness, geometry, and topography, chemical stimulus, like varying the surface chemistry, and biochemical stimuli such as cytokines, hormones, small molecules, and herbal extracts have been studied but have yet to be translated to industrial manufacturing practice. In this review, we describe the role of those stimuli on h-MSC manufacturing, and how these stimuli positively promote h-MSC properties, impacting the cell manufacturing field for cell-based therapies. In addition, we discuss other process considerations such as bioreactor design, good manufacturing practice, and the importance of the cell donor and ethics factors for manufacturing potent h-MSC.
引用
收藏
页码:519 / 535
页数:17
相关论文
共 143 条
  • [1] Human mesenchymal stem cells modulate allogeneic immune cell responses
    Aggarwal, S
    Pittenger, MF
    [J]. BLOOD, 2005, 105 (04) : 1815 - 1822
  • [2] FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling
    Ahn, Hee-Jin
    Lee, Woo-Jung
    Kwack, KyuBum
    Do Kwon, Young
    [J]. FEBS LETTERS, 2009, 583 (17): : 2922 - 2926
  • [3] Mesenchymal Stem Cell Fate: Applying Biomaterials for Control of Stem Cell Behavior
    Anderson, Hilary J.
    Sahoo, Jugal Kishore
    Ulijn, Rein V.
    Dalby, Matthew J.
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2016, 4
  • [4] Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids
    Ankrum, James A.
    Dastidar, Riddhi G.
    Ong, Joon Faii
    Levy, Oren
    Karp, Jeffrey M.
    [J]. SCIENTIFIC REPORTS, 2014, 4
  • [5] Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems
    Badenes, Sara M.
    Fernandes, Tiago G.
    Rodrigues, Carlos A. V.
    Diogo, Maria Margarida
    Cabral, Joaquim M. S.
    [J]. JOURNAL OF BIOTECHNOLOGY, 2016, 234 : 71 - 82
  • [6] Baker BM, 2015, NAT MATER, V14, P1262, DOI [10.1038/nmat4444, 10.1038/NMAT4444]
  • [7] Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion
    Baxter, MA
    Wynn, RF
    Jowitt, SN
    Wraith, JE
    Fairbairn, LJ
    Bellantuono, I
    [J]. STEM CELLS, 2004, 22 (05) : 675 - 682
  • [8] Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow
    Bieback, Karen
    Hecker, Andrea
    Kocaoemer, Asli
    Lannert, Heinrich
    Schallmoser, Katharina
    Strunk, Dirk
    Klueter, Harald
    [J]. STEM CELLS, 2009, 27 (09) : 2331 - 2341
  • [9] Interleukin-1 beta enhances human multipotent mesenchymal stromal cell proliferative potential and their ability to maintain hematopoietic precursor cells
    Bigildeev, Alexey E.
    Zezina, Ekaterina A.
    Shipounova, Irina N.
    Drize, Nina J.
    [J]. CYTOKINE, 2015, 71 (02) : 246 - 254
  • [10] ANTIPROLIFERATIVE AND CHEMOMODULATORY EFFECTS OF INTERFERON-GAMMA ON DOXORUBICIN-SENSITIVE AND DOXORUBICIN-RESISTANT TUMOR-CELL LINES
    BORSELLINO, N
    CRESCIMANNO, M
    FLANDINA, C
    LEONARDI, V
    RAUSA, L
    DALESSANDRO, N
    [J]. ANTI-CANCER DRUGS, 1993, 4 (02) : 265 - 272